medicineのメーカーや取扱い企業、製品情報、参考価格、ランキングをまとめています。
イプロスは、 製造業 ・ BtoB における情報を集めた国内最大級の技術データベースサイトです。

medicine - メーカー・企業38社の製品一覧とランキング

更新日： 集計期間:Dec 24, 2025～Jan 20, 2026
※当サイトの各ページの閲覧回数を元に算出したランキングです。

medicineのメーカー・企業ランキング

更新日： 集計期間:Dec 24, 2025～Jan 20, 2026
※当サイトの各ページの閲覧回数を元に算出したランキングです。

  1. マーケットリサーチセンター Tokyo//Service Industry
  2. null/null
  3. Tohoku Techno Arch Co., Ltd. Miyagi//Educational and Research Institutions
  4. 4 バイオマテックジャパン Hokkaido//Pharmaceuticals and Biotechnology
  5. 5 KANTO CHEMICAL CO., INC. Biochemical Dept Tokyo//Chemical
企業ランキングへ

medicineの製品ランキング

更新日： 集計期間:Dec 24, 2025～Jan 20, 2026
※当サイトの各ページの閲覧回数を元に算出したランキングです。

  1. Pharmaceutical CDMO services 大塚化学
  2. Ouchi Shinko Chemical Industry Co., Ltd. 須賀川市 経済環境部商工課
  3. Contract development and manufacturing (CDMO) business for mid-sized molecules (oligonucleotides and peptides) active pharmaceutical ingredients.
  4. Natural Proteoglycan, the Herbal Medicine of the Sea バイオマテックジャパン
  5. 4 For various titrations! The titration "indicator" specified in JIS K8001. KANTO CHEMICAL CO., INC. Biochemical Dept

medicineの製品一覧

286～300 件を表示 ／ 全 590 件

表示件数
[Research Material] Global Market for Treatments of Vulvar Pain

[Research Material] Global Market for Treatments of Vulvar Pain

Global Market for Vulvar Pain Treatment Drugs: Local Anesthetics, Anticonvulsants, Tricyclic Antidepressants, Antibiotics, Hormonal Creams, Nerve Blocks, Others, Hospitals ...

This research report (Global Vulvodynia Treatment Drugs Market) investigates and analyzes the current status and outlook for the global market of vulvar pain treatment drugs over the next five years. It includes information on the overview of the global vulvar pain treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include local anesthetics, anticonvulsants, tricyclic antidepressants, antibiotics, hormone creams, nerve blocks, and others, while the segments by application focus on hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments calculate the market size for vulvar pain treatment drugs by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the vulvar pain treatment drug sector, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for the Treatment of Multidrug-Resistant Bacterial Infections

[Research Material] Global Market for the Treatment of Multidrug-Resistant Bacterial Infections

Global Market for Treatment of Multidrug-Resistant Bacterial Infections: Critical, Medium, High, Cephalosporins, Beta-lactams, Beta-lactamase Inhibitors ...

This research report (Global Multiple Drug Resistance Bacterial Infection Treatment Market) investigates and analyzes the current state and outlook for the global market for the treatment of multidrug-resistant bacterial infections over the next five years. It includes information on the overview of the global multidrug-resistant bacterial infection treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments of the multidrug-resistant bacterial infection treatment market by type include critical, medium, and high, while the segments by application cover cephalosporins, beta-lactams, beta-lactamase inhibitors, oxazolidinones, cyclic lipopeptides, and glycopeptides. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for the treatment of multidrug-resistant bacterial infections. It also includes the market share of major companies in the multidrug-resistant bacterial infection treatment sector, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for Rosacea Treatments

[Research Material] Global Market for Rosacea Treatments

World Market for Rosacea Treatments: Topical, Oral, Drugstores, Hospitals, Others

This research report (Global Rosacea Drugs Market) investigates and analyzes the current status and outlook for the global market for rosacea treatment drugs over the next five years. It includes information on the overview of the global rosacea treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on topical and oral treatments, while the segments by application target drugstores, hospitals, and others. The regional segments calculate the market size for rosacea treatment drugs by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the rosacea treatment drug market, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] The Global Market for Alopecia Treatment

[Research Material] The Global Market for Alopecia Treatment

Global Market for Alopecia Treatment: Topical Medications, Oral Medications, Injectables, Hair Transplant Services, Others, Hospitals, Dermatology and Hair Clinics, Home Healthcare Facilities, Others

This research report (Global Alopecia Treatment Market) investigates and analyzes the current state and outlook for the global market for alopecia treatment over the next five years. It includes information on the overview of the global alopecia treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the alopecia treatment market include topical agents, oral medications, injectables, hair transplant services, and others, while the segments by application cover hospitals, dermatology and hair clinics, home healthcare facilities, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for alopecia treatment. It also includes the market share of major companies in alopecia treatment, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] The Global Market for Swine Respiratory Disease Treatment

[Research Material] The Global Market for Swine Respiratory Disease Treatment

Global Market for Swine Respiratory Disease Treatment: Viruses, Bacteria, Mycoplasma, Parasites, Others, Pharmacies, Veterinary Hospitals, Clinics, Others

This research report (Global Swine Respiratory Disease Treatment Market) investigates and analyzes the current state and outlook for the global market for swine respiratory disease treatment over the next five years. It includes information on the overview of the global swine respiratory disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the swine respiratory disease treatment market target viruses, bacteria, mycoplasma, parasites, and others, while the segments by application focus on pharmacies, veterinary hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for swine respiratory disease treatment. It also includes the market share of major companies in swine respiratory disease treatment, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
【Research Material】Global Market for Lysosomal Storage Disorder (LSD) Treatments

【Research Material】Global Market for Lysosomal Storage Disorder (LSD) Treatments

Global Market for Lysosomal Storage Disorder (LSD) Treatments: Enzyme Replacement Therapy, Stem Cell Therapy, Substrate Reduction Therapy, Others, Hospitals, Clinics, Others

This research report (Global Lysosomal Storage Diseases Therapeutics Mar) investigates and analyzes the current state and outlook for the global market of lysosomal storage disease (LSD) therapeutics over the next five years. It includes information on the global overview of the lysosomal storage disease (LSD) therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for lysosomal storage disease (LSD) therapeutics by type include enzyme replacement therapy, stem cell therapy, substrate reduction therapy, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for lysosomal storage disease (LSD) therapeutics. It also includes the market share of major companies in lysosomal storage disease (LSD) therapeutics, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] The Global Market for Duchenne Muscular Dystrophy Treatment

[Research Material] The Global Market for Duchenne Muscular Dystrophy Treatment

World Market for Duchenne Muscular Dystrophy Treatment: Analgesics, Corticosteroids, Prednisolone, Prednisone, Deflazacort, ...

This research report (Global Duchenne Muscular Dystrophy Therapeutics Market) investigates and analyzes the current state and outlook for the global market for Duchenne muscular dystrophy treatments over the next five years. It includes information on the overview of the global Duchenne muscular dystrophy treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for Duchenne muscular dystrophy treatments by type include analgesics, corticosteroids, prednisolone, prednisone, and deflazacort, while the segments by application focus on hospitals, clinics, and home healthcare. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for Duchenne muscular dystrophy treatments. It also includes the market share of major companies in Duchenne muscular dystrophy treatments, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] The Global Market for Chagas Disease Treatments

[Research Material] The Global Market for Chagas Disease Treatments

World Market for Chagas Disease Treatments: Cz-007, Cz-008, D-121, DNDI-0690, EPLBS-1246, EPLB ...

This research report (Global Chagas Disease Drug Market) investigates and analyzes the current status and outlook for the global market for Chagas disease treatment drugs over the next five years. It includes information on the overview of the global Chagas disease treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Cz-007, Cz-008, D-121, DNDI-0690, EPLBS-1246, EPLBS-967, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments calculate the market size for Chagas disease treatment drugs by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the Chagas disease treatment drug sector, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for Human Immunodeficiency Virus (HIV)-1 Therapeutics

[Research Material] Global Market for Human Immunodeficiency Virus (HIV)-1 Therapeutics

Global Market for Human Immunodeficiency Virus (HIV)-1 Treatment Drugs: Nucleoside Analog Reverse Transcriptase Inhibitors (NRTI), Non-Nucleoside Reverse ...

This research report (Global Human Immunodeficiency Virus (HIV)-1 Therap) investigates and analyzes the current state and outlook for the global market of human immunodeficiency virus (HIV)-1 therapeutics over the next five years. It includes information on the global overview of the HIV-1 therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type for HIV-1 therapeutics include nucleoside analog reverse transcriptase inhibitors (NRTI), non-nucleoside reverse transcriptase inhibitors (NNRTI), entry/fusion inhibitors, protease inhibitors (PI), integrase inhibitors, and co-receptor antagonists. The segments by application focus on hospitals, clinics, and laboratories. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for HIV-1 therapeutics.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for Treatment of Chronic Idiopathic Constipation (CIC)

[Research Material] Global Market for Treatment of Chronic Idiopathic Constipation (CIC)

World Market for Chronic Idiopathic Constipation (CIC) Treatments: Lubiprostone, Linaclotide, Others, Hospitals & Clinics, Outpatient Surgical Centers, Long-term Care...

This research report (Global Chronic Idiopathic Constipation (CIC) Drugs Market) investigates and analyzes the current status and future outlook of the global market for chronic idiopathic constipation (CIC) treatment drugs over the next five years. It includes information on the overview of the global chronic idiopathic constipation (CIC) treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for chronic idiopathic constipation (CIC) treatment drugs by type include lubiprostone, linaclotide, and others, while the segments by application focus on hospitals/clinics, outpatient surgical centers, nursing centers, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for chronic idiopathic constipation (CIC) treatment drugs. It also includes the market share of major companies in the chronic idiopathic constipation (CIC) treatment drug market, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for Chronic Lymphocytic Leukemia (CLL) Treatment Drugs

[Research Material] Global Market for Chronic Lymphocytic Leukemia (CLL) Treatment Drugs

World Market for Chronic Lymphocytic Leukemia (CLL) Treatments: Injectable, Oral, Hospitals, Clinics

This research report (Global Chronic Lymphocytic Leukemia Therapeutics M) investigates and analyzes the current status and outlook for the global market of chronic lymphocytic leukemia (CLL) therapeutics over the next five years. It includes information on the overview of the global CLL therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type for CLL therapeutics focus on injectable and oral forms, while the segments by application target hospitals and clinics. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for CLL therapeutics. It also includes the market share of major companies in the CLL therapeutics sector, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] The Global Market for Atrophic Gastritis Treatment

[Research Material] The Global Market for Atrophic Gastritis Treatment

Global Market for Atrophic Gastritis Treatment: Coatings, Antibiotics, Vitamin B-12, Hospital Pharmacies, Retail Pharmacies, Drugstores, Online Pharmacies

This research report (Global Atrophic Gastritis Treatment Market) investigates and analyzes the current state and outlook for the global market for atrophic gastritis treatment over the next five years. It includes information on the overview of the global atrophic gastritis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the atrophic gastritis treatment market focus on coating agents, antibiotics, and vitamin B-12, while the segments by application target hospital pharmacies, retail pharmacies, drugstores, and online pharmacies. The regional segments calculate the market size for atrophic gastritis treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in atrophic gastritis treatment, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] The Global Market for Castleman Disease Treatment

[Research Material] The Global Market for Castleman Disease Treatment

Global Market for Castleman Disease Treatment: Monoclonal Antibodies, Chemotherapy, Radiation Therapy, Immunotherapy, Corticosteroids, Antiviral Drugs, Disease ...

This research report (Global Castleman Disease Treatment Market) investigates and analyzes the current state and outlook for the global market for Castleman disease treatment over the next five years. It includes information on the overview of the global Castleman disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Castleman disease treatment market include monoclonal antibodies, chemotherapy, radiation therapy, immunotherapy, corticosteroids, and antiviral drugs, while the segments by application focus on hospitals, clinics, and outpatient units. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Castleman disease treatment. It also includes the market share of major companies in Castleman disease treatment, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for Antifungal Drugs for Dermatophyte Nail Infections (DOT)

[Research Material] Global Market for Antifungal Drugs for Dermatophyte Nail Infections (DOT)

World Market for Antifungal Drugs for Dermatophyte Nail Infections: Topical, Oral Therapy, Hospitals, Dermatology and Podiatry Clinics, Independent Pharmacies, Mail-Order Pharmacies, Drugstores

This research report (Global Dermatophytic Onychomycosis Therapeutics (D)) investigates and analyzes the current status and outlook for the global market of dermatophytic onychomycosis therapeutics (DOT) over the next five years. It includes information on the overview of the global dermatophytic onychomycosis therapeutics (DOT) market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for dermatophytic onychomycosis therapeutics (DOT) by type focus on topical and oral therapies, while the segments by application target hospitals, dermatology and podiatry clinics, independent pharmacies, mail-order pharmacies, and drugstores. The regional segments calculate the market size of dermatophytic onychomycosis therapeutics (DOT) by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in dermatophytic onychomycosis therapeutics (DOT), product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] The Global Market for Treatment of Anorexia Nervosa

[Research Material] The Global Market for Treatment of Anorexia Nervosa

World Market for the Treatment of Anorexia Nervosa: Psychotherapy, Pharmacotherapy, Others, Hospitals, Clinics, Home Healthcare, Others

This research report (Global Anorexia Nervosa Treatment Market) investigates and analyzes the current state and outlook for the global market for anorexia nervosa treatment over the next five years. It includes information on the overview of the global anorexia nervosa treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the anorexia nervosa treatment market include psychotherapy, pharmacotherapy, and others, while the segments by application cover hospitals, clinics, home healthcare, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for anorexia nervosa treatment. It also includes the market share of major companies in anorexia nervosa treatment, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録

medicineに関連する検索キーワード

COPYRIGHT © 2001-2026 IPROS CORPORATION ALL RIGHTS RESERVED.